| Literature DB >> 28295529 |
R B R Moreton1, I M Stratton2,3, S J Chave2, H Lipinski3, P H Scanlon2,3.
Abstract
AIMS: To investigate variables at the demographic and primary care practice levels that influence the uptake of diabetic retinopathy screening.Entities:
Mesh:
Year: 2017 PMID: 28295529 PMCID: PMC5485053 DOI: 10.1111/dme.13350
Source DB: PubMed Journal: Diabet Med ISSN: 0742-3071 Impact factor: 4.359
Figure 1Funnel plot indicating diabetic retinopathy screening uptake as a function of number of persons invited for screening at general practitioner (GP) practices using both optometrist (red) and mobile unit (blue) screening. Horizontal line indicates mean uptake across all GP practices. Outer dashed lines indicate limits of variance from the mean to 2 SD and 3 SD.
Uptake of screening (stratified by gender, modality of screening and age group)
| No. invited | No. screened | Percentage screened |
| ||
|---|---|---|---|---|---|
| Total | 21 789 | 17 963 | 82.4 | ||
| By gender | Male | 12 384 | 10 303 | 83.2 | 0.0011 |
| Female | 9 369 | 7 633 | 81.5 | ||
| Not known | 36 | 27 | 75.0 | ||
| By modality of screening | Mobile unit | 6 530 | 5 454 | 83.5 | 0.0061 |
| Optometrist | 15 259 | 12 509 | 82.0 | ||
| By age group | 12–39 | 1 411 | 940 | 66.6 | < 0.0001 |
| 40–59 | 6 039 | 4 727 | 78.3 | ||
| 60–69 | 5 455 | 4 763 | 87.3 | ||
| 70–79 | 5 352 | 4 727 | 88.3 | ||
| 80 and over | 3 531 | 2 805 | 79.4 | ||
| Not known | 1 | 1 | 100.0 |
*Chi‐squared test.
Estimates for 2 level generalized dichotomous models of screening uptake
| Model 1 | Model 2 | Model 3 | |
|---|---|---|---|
| Fixed effects | |||
| Intercept | 1.55 (0.04) | 1.40 (0.07) | 1.63 (0.09) |
| Age group | Yes | Yes | |
| Gender | Yes | Yes | |
| Modality of screening | Yes | Yes | |
| Index of Multiple Deprivation group of general practice | Yes | ||
| Error variance | |||
| Level 2 intercept | 0.114 (0.026) | 0.099 (0.023) | 0.080 (0.021) |
| Model fit | |||
| Model fit – twice the log likelihood | 2024.6 | 1468.6 | 1462.5 |
Results of the generalized mixed models analysis
| Odds ratio | 95% CI |
| ||
|---|---|---|---|---|
| Age group | 12–39 | 0.52 | 0.45 to 0.60 | < 0.0001 |
| 40–59 | 0.95 | 0.85 to 1.05 | 0.29 | |
| 60–69 | 1.76 | 1.56 to 1.98 | < 0.0001 | |
| 70–79 | 1.96 | 1.74 to 2.21 | < 0.0001 | |
| Gender | Female | 0.91 | 0.85 to 0.98 | 0.014 |
| Male | Reference | |||
| Modality of screening | Mobile unit | 0.99 | 0.83 to 1.18 | 0.88 |
| Optometrist | Reference | |||
| General practice Index of Multiple Deprivation score | Group 1 | 0.75 | 0.58 to 0.96 | 0.02 |
| Group 2 | 0.66 | 0.53 to 0.96 | < 0.0001 | |
| Group 3 | 0.80 | 0.63 to 1.02 | 0.070 | |
| Group 4 | 0.82 | 0.66 to 1.01 | 0.063 | |
| Group 5 | Reference |
| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | 8 | 15 | 46.5 | 42.5 | 30 | 32.5 | 25.5 | 34 | 8 | 14 | 3.75 | 22.75 | 22.5 | 16 | 36.5 | 15 |
| Q2 | No | Yes | Yes | Yes | No | Yes | Yes | No | Yes | No | Yes | No | Yes | No | Yes | Yes |
| Q3 | 35 | 5 | 4 | 1 | 11 | 10 | 3 | 2 | 5 | 3 | 1 | 3 | 1 | 10 | 1 | 7 |
| Q4 | > 1 month (4‐6 weeks typically) | < 1 week | < 1 week | < 48 h | > 1 week | < 1 week | > 1 week | < 48 h | > 1 week (7–8 days typically) | < 1 week | < 1 week | > 1 week | < 1 week | > 1 week | < 1 week | < 1 week |
| Q5 | Yes | No | No | Yes | Yes | Yes | Yes | Yes | No | Yes | No | Yes | No | No | No | Yes |
| Q6 | No | No | No | No | No | No | No | No | No | No | No | No | No | No | No | Yes |
| Overall score | 2 | 6 | 11 | 11 | 7 | 9 | 9 | 9 | 5 | 6 | 4 | 7 | 7 | 4 | 9 | 7 |